The report provides a highly detailed and comprehensive 231 pages of analysis covering the competitor and market trends in the CNS market. www.companiesandmarkets.com adds new report: http://www.companiesandmarkets.com/link.asp?id=B31ETAIWI51123 The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities The global CNS disorders market expanded by 8.0% from 2006, to reach total sales of $77.3bn in 2007. This growth has been primarily driven by treatments for AD, ADHD and Parkinson's Disease. The CNS disorders market is one of the largest and fastest growing markets in the pharmaceutical industry. Reimbursement terms continue to be favorable within the area, despite the relatively high risks associated with product development. This is largely due to significant levels of unmet medical...
[read full story]